EUVIMEDEUVIMED entdecken
Vergleichsstudie

Incidence of 180‐day Readmission With CIED Implantation After Percutaneous and Surgical Aortic and Mitral Valve Interventions

Benjamin W Furman, Vardhmaan Jain, Neal K Bhatia, Mikhael F El-Chami iD, Faisal M Merchant, Jingwen Huang

Journal of Cardiovascular Electrophysiology · 2026

DOI: 10.1111/jce.70295 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Benjamin W Furman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Patient Readmission, Mitral Valve, Transcatheter Aortic Valve Replacement, Heart Valve Prosthesis Implantation. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Valvular interventions are associated with conduction disturbances requiring cardiac implantable electronic device (CIED) implantation. While prior studies have focused on early device implantation post‐aortic interventions, less is known about delayed events, comparisons with surgical approaches, and outcomes following mitral interventions.

Objectives

This study aimed to compare the incidence and timing of CIED implantation within 180 days after surgical and transcatheter aortic and mitral valve interventions.

Methods

We analyzed the Nationwide Readmissions Database (2016–2021) to identify patients undergoing transcatheter aortic valve replacement (TAVR), surgical AVR (SAVR), transcatheter mitral valve replacement/repair (TMVR/TEER), or surgical MVR (SMVR). Readmissions within 180 days for CIED implantations were identified. Weighted analyses and Cox proportional‐hazards models adjusted for demographics, comorbidities, and hospital factors were used.

Results

Transcatheter patients were older and had a higher comorbidity burden than surgical patients. The 180‐day readmission rate for CIED implantation was higher after TAVR versus SAVR (2.33% vs. 0.88%; adjusted HR 2.05, 95% CI 1.84–2.29, p < 0.001). Readmissions with CIED implantation occurred earlier following TAVR vs SAVR (median 10 days vs. 49 days). TMVR/TEER and SMVR had similar overall rates at 180 days (1.66% vs. 1.71%; HR 0.97, 95% CI 0.80–1.19, p = 0.80). Compared to aortic valve interventions, where readmissions with CIED implantation clustered early, readmissions with CIED implantation after mitral valve interventions were more evenly distributed over the first 6 months.

Conclusion

Readmissions with CIED implantation within the first 6 months post‐procedure occur earlier following aortic valve compared to mitral valve interventions. Whereas the incidence of readmission for CIED implantation was higher with TAVR compared to SAVR, readmission rates for CIED implantation were comparable over the first 6 months following surgical and percutaneous mitral interventions. These data have implications for the timing and duration of rhythm monitoring after discharge following valve interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient ReadmissionMitral ValveTranscatheter Aortic Valve ReplacementHeart Valve Prosthesis ImplantationDefibrillators, ImplantablePacemaker, ArtificialAortic ValveTranscatheter Mitral Valve ReplacementCardiac Pacing, ArtificialElectric CountershockArrhythmias, CardiacHumansFemaleTime FactorsMaleRisk FactorsIncidenceAged, 80 and overTreatment OutcomeAgedDatabases, FactualRisk AssessmentUnited StatesRetrospective Studies

Stichwörter der Autor:innen

cardiac implantable electronic devicesurgical valvular interventiontranscatheter valvular intervention

Autor:innen und Institutionen

  • Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Mikhael F El-Chami

Zitieren

APA

Furman, B. W., Jain, V., Bhatia, N. K., El-Chami, M. F., Merchant, F. M., & Huang, J. (2026). Incidence of 180‐day Readmission With CIED Implantation After Percutaneous and Surgical Aortic and Mitral Valve Interventions. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70295

Vancouver

Furman BW, Jain V, Bhatia NK, El-Chami MF, Merchant FM, Huang J. Incidence of 180‐day Readmission With CIED Implantation After Percutaneous and Surgical Aortic and Mitral Valve Interventions. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70295

BibTeX
@article{Furman2026,
  author = {Furman, Benjamin W and Jain, Vardhmaan and Bhatia, Neal K and El-Chami, Mikhael F and Merchant, Faisal M and Huang, Jingwen},
  title = {Incidence of 180‐day Readmission With CIED Implantation After Percutaneous and Surgical Aortic and Mitral Valve Interventions},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  doi = {10.1111/jce.70295}
}
Kostenlos starten →